Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (2,777) Arrow Down
Filter Results: (2,777) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (2,777)
    • People  (10)
    • News  (775)
    • Research  (1,586)
    • Events  (2)
    • Multimedia  (31)
  • Faculty Publications  (804)

Show Results For

  • All HBS Web  (2,777)
    • People  (10)
    • News  (775)
    • Research  (1,586)
    • Events  (2)
    • Multimedia  (31)
  • Faculty Publications  (804)
← Page 28 of 2,777 Results →
  • 2016
  • Chapter

Dishonesty Explained: What Leads Moral People To Act Immorally

By: F. Gino and D. Ariely
The last two decades have witnessed what seems to be an increasing number of cases of dishonesty, from corporate corruption and employee misconduct to questionable behaviors during the financial crisis and individual acts of unethical behavior in many spheres of... View Details
Keywords: Behavior; Ethics; Organizations; Attitudes; Financial Crisis
Citation
Find at Harvard
Related
Gino, F., and D. Ariely. "Dishonesty Explained: What Leads Moral People To Act Immorally." In The Social Psychology of Good and Evil. 2nd ed. Edited by Arthur G. Miller. New York: Guilford Press, 2016.
  • January 2001 (Revised May 2003)
  • Case

Novartis Pharma: The Business Unit Model

By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis
In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing).... View Details
Keywords: Restructuring; Recruitment; Product Marketing; Organizational Structure; Problems and Challenges; Health Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.)
  • March 2015 (Revised September 2016)
  • Case

Terrapin Laboratory

By: Richard G. Hamermesh and Joseph B. Fuller
Describes the formation and rapid growth of a drug testing company. The company needs to decide whether to enter the painkiller testing market, in addition to growing its drug treatment center business. The associated teaching materials provide students the opportunity... View Details
Keywords: Business Growth; Entrepreneurial Management; Entrepreneurship; Growth Strategy; Market Entry; Venture Capital; Growth Management; Expansion; Financing and Loans; Health Care and Treatment; Health Testing and Trials; Business Startups; Pharmaceutical Industry; Health Industry
Citation
Educators
Purchase
Related
Hamermesh, Richard G., and Joseph B. Fuller. "Terrapin Laboratory." Harvard Business School Case 315-098, March 2015. (Revised September 2016.)
  • March 2003 (Revised March 2004)
  • Case

P&G Japan: The SK-II Globalization Project

By: Christopher A. Bartlett
Traces changes in P&G's international strategy and structure, culminating in Organization 2005, a reorganization that places strategic emphasis on product innovation rather than geographic expansion and shifts power from local subsidiary to global business management.... View Details
Keywords: Business Subsidiaries; Trade; Globalization; Global Strategy; Innovation Strategy; Business or Company Management; Beauty and Cosmetics Industry; Consumer Products Industry; Hong Kong; Japan; Taiwan; Europe
Citation
Educators
Purchase
Related
Bartlett, Christopher A. "P&G Japan: The SK-II Globalization Project." Harvard Business School Case 303-003, March 2003. (Revised March 2004.)
  • Research Summary

Integrating: A managerial practice that enables implementation in fragmented healthcare environments [Under Review]

In this paper with Michaela Kerrisey, Sara Singer, Nicholas Leydon, and Gordon Schiff, we identify the factors that enabled primary care clinics to overcome implementation barriers and explain how clinic managers can integrate those factors across roles. Our... View Details

  • June 2024
  • Case

Aidoc: Building a Hospital-Centric AI Platform

By: Ariel D. Stern and Susan Pinckney
In 2023, Israel-based AI health care company Aidoc evaluated its future. The company, founded in 2016, had grown from commercializing a single AI product for radiologists to a software platform that could detect 20 conditions and immediately notify care teams of... View Details
Keywords: Business Growth and Maturation; Business Model; Business Organization; Business Startups; Disruption; Cost vs Benefits; Decision Choices and Conditions; Decisions; Private Sector; Entrepreneurial Finance; Global Range; Global Strategy; Globalized Markets and Industries; Governance Compliance; Governance Controls; Governing and Advisory Boards; Policy; Medical Specialties; AI and Machine Learning; Digital Platforms; Digital Transformation; Technology Adoption; Disruptive Innovation; Innovation and Management; Innovation Strategy; Laws and Statutes; Growth and Development Strategy; Growth Management; Distribution; Product Development; Success; Performance Efficiency; Strategic Planning; Research and Development; Risk and Uncertainty; Business Strategy; Competitive Advantage; Value Creation; Health Industry; Israel
Citation
Educators
Purchase
Related
Stern, Ariel D., and Susan Pinckney. "Aidoc: Building a Hospital-Centric AI Platform." Harvard Business School Case 624-046, June 2024.
  • June 2014
  • Article

Improving Value with TDABC

By: Robert S. Kaplan
The article discusses the benefits of time-driven activity-based costing (TDABC) combined with outcomes measurement for healthcare organizations. Topics covered include improving resource efficiency, optimizing care over the complete care cycle, and planning and... View Details
Keywords: Goals and Objectives; Activity Based Costing and Management; Health Care and Treatment; Health Industry
Citation
Find at Harvard
Related
Kaplan, Robert S. "Improving Value with TDABC." hfm (Healthcare Financial Management) 68, no. 6 (June 2014): 76–83.
  • 2013
  • Working Paper

The Appeal of the Appropriate: Accounting, Risk Management, and the Competition for the Supply of Control Systems

By: Anette Mikes
How do certain risk measurements in organizations come to be seen as more reliable and acceptable than others? Taking a multiple-control perspective, I investigate the aftermath of a control debacle at a financial services company (MultiBank), focusing on its insurance... View Details
Keywords: Management Control Systems; Multiple Control Systems; Interactive Control Systems; Performance Measurement; Risk Measurement; Financialization Of Accounting; Institutional Logics; Banking; Risk Management; Fair Value Accounting; Insurance; Financial Services Industry
Citation
Read Now
Related
Mikes, Anette. "The Appeal of the Appropriate: Accounting, Risk Management, and the Competition for the Supply of Control Systems." Harvard Business School Working Paper, No. 12-115, June 2012. (Revised January 2013.)
  • 30 Oct 2012
  • First Look

First Look: October 30

firms. However, once a lawsuit-triggering event like an accounting restatement, missing management guidance, or a sharp stock price decline occurs, there is no difference in the litigation rates between a foreign and comparable U.S. firm.... View Details
Keywords: Sean Silverthorne

    Amy C. Edmondson

    Amy C. Edmondson is the Novartis Professor of Leadership and Management at the Harvard Business School, a chair established to support the study of human interactions that lead to the creation of successful enterprises that contribute to the betterment of... View Details

    Keywords: health care; health care; health care; health care
    • August 2014 (Revised February 2021)
    • Case

    Hospital for Special Surgery (A)

    By: Regina E. Herzlinger and Stacy Schwartz
    Hospital for Special Surgery, a focused factory for orthopedics and joint disease, is contemplating various growth options: further growth in the United Kingdom's National Health Services, management of hospitals in the United States, and/or hospital consulting.... View Details
    Keywords: Health Care and Treatment; Nonprofit Organizations; Growth and Development Strategy; Cross-Cultural and Cross-Border Issues; Expansion; Health Industry; United Kingdom; United States
    Citation
    Educators
    Purchase
    Related
    Herzlinger, Regina E., and Stacy Schwartz. "Hospital for Special Surgery (A)." Harvard Business School Case 315-012, August 2014. (Revised February 2021.)
    • January 1988
    • Case

    Santa Clara County Transportation Agency (A)

    A manager is confronted with a choice between promoting a man, recommended through a careful evaluation process, or a woman, who scored slightly lower in the same process, and who is seen as a trouble maker. Appendix summarizes legal issues in affirmative action... View Details
    Keywords: Decision Choices and Conditions; Laws and Statutes; Gender
    Citation
    Educators
    Purchase
    Related
    Heckscher, Charles C. "Santa Clara County Transportation Agency (A)." Harvard Business School Case 488-039, January 1988.
    • 24 Jan 2017
    • First Look

    First Look at New Research: January 24, 2017

    Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=52122 January 2017 Strategic Finance Managing Healthcare Costs and Value By: Kaplan, Robert S., Michael E. Porter, and Mark L. Frigo Abstract—Rising health View Details
    Keywords: Sean Silverthorne
    • October 2023
    • Article

    What Does the Inflation Reduction Act Mean for Patients and Physicians?

    By: Amitabh Chandra and Benedic Ippolito
    The debate around prescription drug measures in the recently passed U.S. Inflation Reduction Act (IRA), which limit some patients’ out-of-pocket costs, has not fully addressed their effect on physicians and patients via their effect on payers. Reducing patients’ costs... View Details
    Keywords: Government Legislation; Price; Health Care and Treatment
    Citation
    Find at Harvard
    Purchase
    Related
    Chandra, Amitabh, and Benedic Ippolito. "What Does the Inflation Reduction Act Mean for Patients and Physicians?" NEJM Catalyst Innovations in Care Delivery 4, no. 10 (October 2023).
    • 06 Sep 2019
    • Blog Post

    The Business of Medicine: MD/MBA Students Having an Impact

    his tuition by trading his own stocks. This fall, Ameen will begin classes at Harvard Business School, where he says he hopes to strengthen the financial, analytical, and leadership skills that will help him understand how to work within the current health View Details
    • 16 Jul 2008
    • Op-Ed

    What Should Employers Do about Health Care?

    ignored health care altogether, leaving it to government or dutifully paying their mandated health contributions. Many U.S. employers are dropping health benefits or hoping for reforms that will transfer responsibility for health... View Details
    Keywords: by Michael E. Porter, Elizabeth O. Teisberg & Scott Wallace; Health
    • 09 Jun 2016
    • Video

    Hold Onto Your Complexity: Bringing Multiple Identities to Work

    • 22 Jul 2014
    • First Look

    First Look: July 22

    use process mapping and time-driven activity-based costing to measure the costs of treating patients over a complete cycle of care for a specific medical condition. With valid outcome and cost information, View Details
    Keywords: Sean Silverthorne
    • 14 Apr 2017
    • News

    Professor John Quelch Elected to American Academy of Arts & Sciences

    • November 2003
    • Case

    Procter & Gamble 2000 (A): The SpinBrush and Innovation at P&G

    By: William A. Sahlman and Ryland Matthew Willis
    Describes a set of decisions confronting some managers in the oral care division of Procter & Gamble. They must decide whether to buy a company that has developed an inexpensive, battery-operated toothbrush. The company's product has done well in one market, but... View Details
    Keywords: Valuation; Innovation and Management; Corporate Entrepreneurship; Mergers and Acquisitions; Product Launch; Corporate Finance; Retail Industry
    Citation
    Educators
    Purchase
    Related
    Sahlman, William A., and Ryland Matthew Willis. "Procter & Gamble 2000 (A): The SpinBrush and Innovation at P&G." Harvard Business School Case 804-099, November 2003.
    • ←
    • 28
    • 29
    • …
    • 138
    • 139
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.